Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 8e-05 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |